Augmentation of hematopoiesis by fibroblast-mediated interleukin-6 gene therapy in mice with chemotherapy.
J Interferon Cytokine Res. 1998.
PMID: 9568724
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1995 | 1 |
| 1998 | 1 |
| 2026 | 0 |
Search Results
2 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Augmentation of hematopoiesis by fibroblast-mediated interleukin-6 gene therapy in mice with chemotherapy.
J Interferon Cytokine Res. 1998 Apr;18(4):227-33. doi: 10.1089/jir.1998.18.227.
J Interferon Cytokine Res. 1998.
PMID: 9568724
Murine fibroblast NIH3T3 cells engineered to secrete interleukin-6 (NIH3T3-IL-6) were implanted intraperitoneally into mice and observed for their hematopoietic effects with or without 5-fluorouracil (5-FU) administration. ...The numbers of CFU-GM and CFU-MK …
Murine fibroblast NIH3T3 cells engineered to secrete interleukin-6 (NIH3T3-IL-6) were implanted intraperitoneally into mice …
[Experimental study on in vivo hematopoietic regulation of interleukin-6 gene therapy].
Zhonghua Yi Xue Za Zhi. 1995 Apr;75(4):220-3, 255.
Zhonghua Yi Xue Za Zhi. 1995.
PMID: 7788552
Chinese.
We observed the effect of fibroblast mediated human IL-6 gene therapy on hematopoiesis. The platelet counts started to increase at day 4 after implantation of IL-6 highly secreting fibroblast cells and peaked at day 10 and lasted at high level f …
We observed the effect of fibroblast mediated human IL-6 gene therapy on hematopoiesis. The platelet coun …
Cite